Name

Megestrol Acetate

Alternate Names

Apo-Megestrol
BDH-1298
Compound 5071
Magace
Megace
SC-10363

Abbreviations

None

Category

Hormones and hormonal mechanisms
AIDS drug

Subcategory

Progestin

NSC Number

71423
071423

Primary Site

Breast cancer
endometrial cancer

Histology

None

Remarks

A synthetic progestin; appetite stimulant. FDA approved palliative uses in advanced endometrial carcinoma and advanced breast carcinoma. Also for the treatment of anorexia, cachexia, and significant weight loss in patients with acquired immunodeficiency syndrome; administered orally.

Megace may be coded as first course treatment (hormone) when given in combination with other antineoplastic drugs. Megace is most often given for advanced breast and endometrial cancers, but it's use is not limited to advanced/metastic/recurrent disease.

DO NOT code when given as an appetite stimulant.

Coding

Please see remarks for additional information
Glossary